BU-NOT-SET

CONTACT US
Product Quality in the Advanced Therapies Manufacturing
  • Biologics
men in lab
White paper
Navigating ATMP fill and finish complexities
  • Biologics
lab
Insight
The power of analytics and AI in the era of continuous RNA manufacturing
  • Biologics
people in a lab
Insight
Reimagining the RNA manufacturing space: An interview with ReciBioPharm’s leaders
  • Biologics
person in lab
Insight
Unlocking the potential of mRNA: Inside ReciBioPharm's Watertown site
  • Biologics
mRNA
Insight
Industry 5.0 in action: AI-driven continuous manufacturing for RNA therapeutics
  • Biologics
vaccine in bottles
Insight
Choosing the optimal container format for sterile drug products
  • Drug product
  • Manufacturing
Containers for sterile drug products
Insight
FDA inspection success at Recipharm’s site in Bengaluru, India
  • Manufacturing
Two people looking at a printed document
Insight
Lyophilisation Services
  • Drug product
  • Manufacturing
bottles
Fact sheet
Insight
  • Drug product
  • Industry trends
Three challenges pharma companies can overcome when choosing the right OSD partner
Insight
  • Sustainability
Sustainable pharmaceutical supply chains with the Science Based Targets initiative
Insight
How CDMO partnerships can accelerate vaccine development
Insight
  • Analytical chemistry
  • Drug product
Optimising extractables and leachables testing
Fact sheet
  • Drug product
  • Manufacturing
Ready-to-use (RTU) pre-filled syringes and cartridges system
Insight
  • Drug product
  • Manufacturing
Recipharm’s latest investment will help meet blow-fill-seal (BFS) demand
Insight
  • Drug product
  • Industry trends
Which biologics trends in the OSD space are set to impact drug development in 2023?
Insight
  • Drug product
  • Industry trends
What are the key learnings from 2022 in pharma?
Insight
  • Drug product
  • Manufacturing
Overcoming the pitfalls of pre-filled syringe filling